MYO-101 Phase 1/2a systemic gene therapy trial for LGMD2E to begin in early 2018 New Albany, OH, 13 December 2017 – Myonexus Therapeutics, Inc. (Myonexus), a clinical-stage biotechnology company developing… Read more
Myonexus Therapeutics is a clinical stage gene therapy company developing first-ever gene treatments for multiple types of limb-girdle muscular dystrophy (LGMD), a group of progressive, debilitating musculoskeletal genetic diseases that… Read more
The Columbus-based startup, Noxsano is a reminder that not all medical technology comes from state-of-the-art laboratories in large research institutions. Like Microsoft and Hewlett Packard, the technology at the core… Read more
Nanofiber Solutions™, an Ohio-based regenerative medicine company, is developing a new class of medical implants for soft tissue and organ repair and replacement. The firm provides absorbable, three-dimensional (3-D) nanofiber… Read more
Adams outlines a simple and effective market validation and testing strategy that is proven, giving entrepreneurs and managers the ability to improve the prospect of product success dramatically.
Business models are not a one-size fits all; considerations vary based on the industry, the validated markets, and the value proposition that the startup offers its customers. Rev1’s venture services… Read more
Well managed and governed companies raise capital more effectively, have happier, and more engaged employees.
Here’s a real-world example of how Simple-Fill, an Ohio State University spinout, continually worked with industry leaders to validate the problem
The executive summary is like the cliff’s notes version of your business plan. It is your chance to draw in a potential investor so that they are eager to learn… Read more